Skip to content

Clinical trials

Completed Phase 3 Liver Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Diseases Phase: Phase 3 Status: Completed Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20052
20081
20091
20101
20112
20121
20134
20141
20152
20162
20182
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences7
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)5
Mirum Pharmaceuticals, Inc.3
National Heart, Lung, and Blood Institute (NHLBI)2
Centre Hospitalier Universitaire, Amiens1
HepNet Study House, German Liverfoundation1
Imunon1
Janssen R&D Ireland1
Nycomed1
Taipei City Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Diseases27
Hepatitis C10
Digestive System Diseases9
Hepatitis C, Chronic8
Virus Diseases8
Hepatitis7
Hepatitis, Viral, Human7
Fibrosis5
Hepatitis, Chronic5
RNA Virus Infections5

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.